Arcturus Therapeutics Holdings Inc at JPMorgan Healthcare Conference Transcript
Good afternoon and welcome, everyone. I'm Collette van Buchem. I'm an associate on the healthcare team at JPMorgan in New York.
Today, it is my pleasure to introduce Arcturus Therapeutics.
Joe Payne, CEO and President, will be presenting today. I'll pass it over to you.
All right. Thanks, Colette. Thanks, JPMorgan.
Arcturus Therapeutics is a messenger RNA medicines and therapeutics company. We have next-generation technologies that we leverage to do some exciting new innovative medicines.
We were founded in 2013. We're based in San Diego. But what has occurred in the biotech industry has also impacted Arcturus in that we are now a much leaner and more focused company than we were a couple of years ago. Our employee count is now at approximately 100. We're focused on some value-creating assets that we'll be emphasizing or reviewing today.
On the left-hand side of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
